Video Experimental Relacionado
Updated: Jan 29, 2026

09:56
Hierarchical and Programmable One-Pot Oligosaccharide Synthesis
Published on: September 6, 2019
7.3K
Síntesis de oligosacáridos y innovación traslacional
Larissa Krasnova1, Chi-Huey Wong1,2
1Department of Chemistry , The Scripps Research Institute , 10550 N. Torrey Pines Road , La Jolla , California 92037 , United States.
Journal of the American Chemical Society
|February 5, 2019
Resumen
La síntesis de glicanos humanos complejos para uso clínico es un desafío. Esta perspectiva evalúa estrategias sintéticas prometedoras para los oligosacáridos y los glucoconjugados terapéuticos.
Área de la Ciencia:
- Química de los carbohidratos
- Glicobiología
- Química medicinal
Sus antecedentes:
- La traducción de la glucosilación humana a aplicaciones clínicas requiere muestras homogéneas de oligosacáridos y glucoconjugados.
- La complejidad estructural y la variabilidad de los glicanos plantean desafíos sintéticos significativos.
Objetivo del estudio:
- Proporcionar una evaluación crítica de las estrategias sintéticas prometedoras para los oligosacáridos y los glucoconjugados.
- Orientar a los investigadores en la búsqueda de diversos métodos de síntesis para objetivos terapéuticos.
Principales métodos:
- Revisión y evaluación crítica de las metodologías de síntesis de oligosacáridos existentes y emergentes.
- Centrarse en las estrategias aplicables a los glicanos terapéuticamente relevantes.
Principales resultados:
- Identificación de los principales desafíos en la síntesis de glicanos complejos.
- Evaluación de las fortalezas y limitaciones de los diversos enfoques sintéticos.
- Destacando estrategias prometedoras para acceder a estructuras de glicano homogéneas.
Conclusiones:
- La síntesis efectiva de oligosacáridos y glucoconjugados homogéneos es crucial para la traducción clínica.
- La selección estratégica de los métodos de síntesis es vital para superar la complejidad de los glicanos.
- Los avances en las estrategias sintéticas son esenciales para el desarrollo de terapias basadas en glicanos.
Videos de Conceptos Relacionados
Oligosaccharide Assembly
3.7K
Protein glycosylation starts in the ER lumen and continues in the Golgi apparatus. Glycosyltransferases catalyze the addition of sugar molecules or glycosylation of proteins. Usually, these enzymes add sugars to the hydroxyl groups of selected serine or threonine residues to form O-linked glycans or the amino groups of asparagine residues to form N-linked glycans. Different positions on the same polypeptide chain can contain differently linked glycans.
Multiple sugar molecules that may or may...
Multiple sugar molecules that may or may...
3.7K
Translation
156.3K
Lesson: Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of...
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of...
156.3K
Translation
17.8K
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
Proteins are...
Translation Produces the Building Blocks of Life
Proteins are...
17.8K
Initiation of Translation
39.0K
Initiating translation is complex because it involves multiple molecules. Initiator tRNA, ribosomal subunits, and eukaryotic initiation factors (eIFs) are all required to assemble on the initiation codon of mRNA. This process consists of several steps that are mediated by different eIFs.
First, the initiator tRNA must be selected from the pool of elongator tRNAs by eukaryotic initiation factor 2 (eIF2). The initiator tRNA (Met-tRNAi) has conserved sequence elements including modified bases at...
First, the initiator tRNA must be selected from the pool of elongator tRNAs by eukaryotic initiation factor 2 (eIF2). The initiator tRNA (Met-tRNAi) has conserved sequence elements including modified bases at...
39.0K
Termination of Translation
27.7K
The large ribosomal subunit has several important structures essential to translation. These include the peptidyl transferase center (PTC) - which is the site where the peptide bond is formed - and a large, internal, water-filled tube through which the nascent polypeptide moves. This latter structure is called the Peptide Exit Tunnel, and it begins at the PTC and spans the body of the large ribosomal subunit. During translation, as the nascent polypeptide chain is synthesized, it passes through...
27.7K
Improving Translational Accuracy
14.9K
Base complementarity between the three base pairs of mRNA codon and the tRNA anticodon is not a failsafe mechanism. Inaccuracies can range from a single mismatch to no correct base pairing at all. The free energy difference between the correct and nearly correct base pairs can be as small as 3 kcal/ mol. With complementarity being the only proofreading step, the estimated error frequency would be one wrong amino acid in every 100 amino acids incorporated. However, error frequencies observed in...
14.9K

